Management of cardiovascular disease using an mHealth tool: a randomized clinical trial

• DOI: 10.1038/s41746-021-00535-z
• Publication Date: 2021-12-03T11:03:41Z
• Authors: Si-Hyuck Kang; Hyunyoung Baek; Jihoon Cho; Seok Kim; Hee Hwang; Wonjae Lee; Jin Joo Park; Yeonyee E. Yoon; Chang-Hwan Yoon; Young-Seok Cho; Tae-Jin Youn; Goo-Yeong Cho; In-Ho Chae; Dong-Ju Choi; Sooyoung Yoo; Jung-Won Suh
• Keywords: mHealth; Clinical endpoint; Post-hoc analysis

Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity worldwide. This randomized controlled, single-center, open-label trial tested the impact mobile health (mHealth) service tool optimized for ASCVD patient care. Patients with clinical were enrolled randomly assigned to intervention or control group. Participants in group provided smartphone application named HEART4U, while dedicated interface integrated into electronic healthcare record system was treating physicians. A total 666 patients enrolled, 333 each The estimated baseline 10-year risk 9.5% 10.8% groups, respectively, as assessed by pooled cohort equations. primary study endpoint change at six months. increased 1.3% 1.1%, which did not differ significantly (P = 0.821). None secondary endpoints showed significant differences between groups. post-hoc subgroup analysis benefit greater if participant accessed more frequently. present demonstrated no benefits associated use mHealth terms predefined stable ASCVD. However, it also suggested that motivating frequently may lead benefit. Better design positive user experience needs be considered developing future tools care.Trial Registration: ClinicalTrials.gov NCT03392259.